Mainolfi Nello 4
4 · Kymera Therapeutics, Inc. · Filed Mar 4, 2026
Insider Transaction Report
Form 4
Mainolfi Nello
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
[F1]2026-03-02+215,000→ 215,000 totalExercise: $90.10Exp: 2036-03-01→ Common Stock (215,000 underlying)
Footnotes (1)
- [F1]The shares underlying this stock option shall vest in forty-eight (48) equal monthly installments following March 2, 2026, subject to the reporting person's continued employment through each vesting date.
Signature
/s/ Bruce Jacobs, as Attorney-in-Fact|2026-03-04